Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Short Interest Update
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 144,500 shares, an increase of 6.3% from the August 30th total of 136,000 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily volume of 68,900 shares, the days-to-cover ratio is presently 2.1 days.
Separately, ValuEngine upgraded Infinity Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $2.67.